Skip to main content
. 2023 Dec 18;52(4):1930–1952. doi: 10.1093/nar/gkad1155

Figure 7.

Figure 7.

Constitutive nuclear localization of AGO2 (NLS-AGO2 knock-in) phenocopies overconfluent culture. (A) Western blot validation of AGO2 nuclear localization in CRISPR/Cas9-NLS-AGO2 knock-in HCT116 (NLS-AGO2). (B) Immunofluorescence validation of AGO2 nuclear localization in NLS-AGO2 compared to WT HCT116. (C–E) RT-qPCR results describing top candidate miRISC target expression changes in NLS-AGO2 cell line relative to WT (N = 3). Significance denoted by *’s with (C) IGF1R, P= 0.0004, (D) OLFML2A, P= 0.005, (E) NOTCH3, P= 0.03.